ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Systems-level integration of machine learning, SHAP explainability, PCA, and network topology reveals multitarget protective actions of tannic acid against doxorubicin toxicity in pentose phosphate pathway.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Physical activity and oxidative stress biomarkers in humans: a systematic review and quantitative meta-analysis.BMC sports science, medicine & rehabilitation · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Doxorubicin (DOX) is an effective chemotherapeutic agent; however, its clinical use is limited due to dose-dependent toxicities. This study aimed to investigate the potential protective effect of tannic acid (TA), a natural polyphenol with antioxidant properties, against DOX-induced alterations in oxidative pentose phosphate pathway (PPP) enzymes in rat lung tissue. Male rats were treated with DOX, TA, or a combination of both. The activity and gene expression levels of PPP enzymes (G6PD and 6PGD), antioxidant enzymes (GPx, SOD, and CAT), and oxidative stress markers (GSH and MDA) were evaluated. DOX administration significantly reduced G6PD and 6PGD activity and gene expression, decreased GSH levels, and increased MDA content. Co-treatment with TA reversed these biochemical alterations and improved antioxidant status. To elucidate the mechanistic drivers of group discrimination, an explainable random forest classifier was developed. SHAP (Shapley Additive Explanations) analysis identified 6PGD activity, G6PD/6PGD mRNA expression, GPX and CAT activities, IL-6 mRNA, GSH, and MDA as the most influential biomarkers determining DOX toxicity profiles. In addition to conventional biochemical and molecular assessments, multivariate statistical analyses (PCA), correlation network mapping, and explainable machine learning approaches (random forest with SHAP analysis) were employed to characterize the systemic oxidative and inflammatory alterations induced by DOX and their modulation by TA. The classifier achieved excellent discriminative performance, with a low out-of-bag Brier score (0.138). TA demonstrates a protective effect against DOX-induced oxidative stress and enzymatic impairment in the rat lung, suggesting its potential as a supportive therapeutic agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.